Jeff Baxter, VBI Vaccines CEO (ChromaDex)

VBI Vac­cines ex­ecs tout ap­proval of new triple-anti­gen he­pati­tis B shot. Can they sell it?

VBI Vac­cines cel­e­brat­ed a new ap­proval Wednes­day morn­ing, an­nounc­ing the FDA has green­light­ed its he­pati­tis B vac­cine for adults. But ques­tions re­main on how well …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.